citalopram has been researched along with alprazolam in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.33) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 7 (29.17) | 24.3611 |
2020's | 3 (12.50) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ostrow, D | 1 |
Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
Hofmann, M; Vidoni, F | 1 |
Ali, Z; Brady, JP | 1 |
Hall, J; Herrmann, N; Naranjo, CA; Sproule, BA | 1 |
Hogg, S; Jessa, M; Michan, L | 1 |
Marlowe, K; Schirgel, D | 1 |
Savas, HA; Virit, O | 1 |
Basu, S; Dash, A; Kumar, A; Muthusami, S | 1 |
Ahmad, J; Ain, MR; Akhtar, M; Al-Ghamdi, SS; Ibrahim, IA; Khan, W; Khanam, R; Shahzad, N | 1 |
Baltás, P | 1 |
Oldani, M; Suss, T | 1 |
Che Hamzah, J; Hassan Basri, M; Khoo, CS | 1 |
Esfahani, H; Golbaz, S; Nabizadeh, R; Rastkari, N; Yaghmaeian, K; Zamanzadeh, M | 1 |
2 review(s) available for citalopram and alprazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
3 trial(s) available for citalopram and alprazolam
Article | Year |
---|---|
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Area Under Curve; Citalopram; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans | 2003 |
20 other study(ies) available for citalopram and alprazolam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
[SSRI-induced akathesia].
Topics: Adjustment Disorders; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Neurologic Examination; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders | 1996 |
Alprazolam, citalopram, and clomipramine for stuttering.
Topics: Alprazolam; Anti-Anxiety Agents; Citalopram; Clomipramine; Drug Therapy, Combination; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Stuttering | 2000 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Quetiapine and citalopram: aetiological significances in serotonin syndrome.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Treatment Outcome | 2006 |
Citalopram-associated spontaneous ejaculations.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Ejaculation; Humans; Male; Panic Disorder | 2008 |
Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram.
Topics: Acute Disease; Alprazolam; Anti-Anxiety Agents; Anxiety; Basal Ganglia Diseases; Chest Pain; Child; Citalopram; Dyskinesia, Drug-Induced; Humans; Male; Selective Serotonin Reuptake Inhibitors | 2009 |
Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Atenolol; Biomarkers; Citalopram; Drug Interactions; Female; Glutathione; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar | 2014 |
[Family malediction in the background of panic disorder -- case report].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Cognitive Behavioral Therapy; Drug Administration Schedule; Drug Therapy, Combination; Family; Female; Humans; Panic Disorder | 2013 |
Little Helpers No More: A Framework for Collaborative Deprescribing of Benzodiazepines in Older Adults.
Topics: Acetaminophen; Aged; Alprazolam; Benzodiazepines; Citalopram; Deprescriptions; Drug Combinations; Female; Humans; Hypnotics and Sedatives; Male; Oxycodone; Selective Serotonin Reuptake Inhibitors | 2020 |
Dilated pupils in an anxious patient.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Female; Humans; Mydriasis; Young Adult | 2021 |
Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Environmental Monitoring; Humans; Hypnotics and Sedatives; Iran; Pharmaceutical Preparations; Sertraline; Thioridazine; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2023 |